{"id":4731,"date":"2023-07-26T20:13:58","date_gmt":"2023-07-26T18:13:58","guid":{"rendered":"https:\/\/www.tarosdiscovery.com\/unkategorisiert\/protection-of-pancreatic-islets-from-oxidative-cell-death\/"},"modified":"2024-01-26T12:33:47","modified_gmt":"2024-01-26T11:33:47","slug":"protection-of-pancreatic-islets-from-oxidative-cell-death","status":"publish","type":"post","link":"https:\/\/www.tarosdiscovery.com\/de\/news\/protection-of-pancreatic-islets-from-oxidative-cell-death\/","title":{"rendered":"Protection of pancreatic islets from oxidative cell death"},"content":{"rendered":"\t\t
Okka Scholz, Elena Hu\u00df, Silke Otter, Diran Herebian, Anna Hamacher, Laura Mariana Levy, Stanimira Hristeva, Miguel Sanz, Haresh Ajani, Alfredo Rodriguez Puentes, Torsten Hoffmann, Jens Hogeback, Anke Unger, Susanne Terheyden, Michelle Reina do Fundo, Bedair Dewidar, Michael Roden, Eckhard Lammert<\/p>\n
Molecular Metabolism, July 2023, https:\/\/doi.org\/10.1016\/j.molmet.2023.101775<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Abstract:<\/strong><\/p>\n Dextromethorphan (DXM) is a commonly used antitussive medication with positive effects in people with type 2 diabetes mellitus, since it increases glucose tolerance and protects pancreatic islets from cell death. However, its use as an antidiabetic medication is limited due to its central nervous side effects and potential use as a recreational drug. Therefore, we recently modified DXM chemically to reduce its blood\u2013brain barrier (BBB) penetration and central side effects. However, our best compound interacted with the cardiac potassium channel hERG (human ether-\u00e0-go-go-related gene product) and the \u03bc-opioid receptor (MOR). Thus, the goal of this study was to reduce the interaction of our compound with these targets, while maintaining its beneficial properties.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t Medizinalchemie<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Das internationale Team von 91Ö±²¥ verf\u00fcgt kombiniert \u00fcber mehr als 180 Jahre Erfahrung in der pharmazeutischen F&E. Als Team haben wir an mehr als 120 biomolekularen\u2026<\/p>\n Performance Chemicals<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Unsere Kunden profitieren von der Synthese erster kg-Mengen innovativer Fein- und Spezialchemikalien, Effizienzsteigerung und Kostensenkung von\u2026<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tInteressiert Sie diese Publikation? Kontaktieren Sie unsere Wissenschaftler<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tWirkstoffforschung<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tAuftragssynthese<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t